Onkure Therapeutics, Inc. · NASDAQ:OKUR

Anders Hove reported a 9.50% stake in Onkure Therapeutics, Inc. (Schedule 13G)

Event Mar 27, 2026 · Filed Apr 1, 2026

Anders Hove reported a 9.50% stake in Onkure Therapeutics, Inc., 3,924,037 shares, as a passive investor on Mar 27, 2026. Filed Apr 1, 2026 (Schedule 13G).

Stake
9.50%
Shares
3,924,037
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
ACORN BIOVENTURES, L.P.4.50%1,854,525
ACORN CAPITAL ADVISORS GP, LLC4.50%1,854,525
ACORN BIOVENTURES 2, L.P.5.00%2,069,512
Acorn Capital Advisors GP 2, LLC5.00%2,069,512
Anders Hove9.50%3,924,037

Source

View original at SEC

Related